Davide Salzano, Barbara Shannon, Claire Grierson, Lucia Marucci, Nigel J. Savery and Mario di Bernardo*,
{"title":"","authors":"Davide Salzano, Barbara Shannon, Claire Grierson, Lucia Marucci, Nigel J. Savery and Mario di Bernardo*, ","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"14 7","pages":"XXX-XXX XXX-XXX"},"PeriodicalIF":3.7,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acssynbio.4c00862","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144646069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mackenzie Thornbury, Adrien Knoops, Iain Summerby-Murray, James Dhaliwal, Sydney Johnson, Joseph Christian Utomo, Jaya Joshi, Lauren Narcross, Gabriel Remondetto, Michel Pouliot, Malcolm Whiteway and Vincent J. J. Martin*,
{"title":"","authors":"Mackenzie Thornbury, Adrien Knoops, Iain Summerby-Murray, James Dhaliwal, Sydney Johnson, Joseph Christian Utomo, Jaya Joshi, Lauren Narcross, Gabriel Remondetto, Michel Pouliot, Malcolm Whiteway and Vincent J. J. Martin*, ","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"14 7","pages":"XXX-XXX XXX-XXX"},"PeriodicalIF":3.7,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acssynbio.5c00096","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144646601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yang Li, Mingxiong Liu, Changyang Yang, Yujia Zheng, Guiping Xu, Hongxin Fu, Jufang Wang
{"title":"Engineering Temperature-Powered Synthetic Multilayer Molecular Bioswitch for High-Level Pyruvate Derivative Production in <i>Escherichia coli</i>.","authors":"Yang Li, Mingxiong Liu, Changyang Yang, Yujia Zheng, Guiping Xu, Hongxin Fu, Jufang Wang","doi":"10.1021/acssynbio.5c00269","DOIUrl":"https://doi.org/10.1021/acssynbio.5c00269","url":null,"abstract":"<p><p>Microbial engineering and genetically encoded bioswitches provide an excellent platform for the production of high-value biochemicals. However, the synthesis of biobased compounds associated with central pathways or multiple bypasses is often restricted by robust central metabolism, incompatible metabolic homeostasis, and limited genetic tools. Here, a programmable and bifunctional temperature- and pyruvate-responsive biosensor was designed to establish an efficient biosynthesis platform for pyruvate derivatives. Especially, the novel variant L185P of regulator CI<sup>857</sup> exhibited a 37.08% improvement in thermostability by forming a ring oscillation and a more rigid structure. Subsequently, the tool <u>TPLC</u>, based on <u>t</u>hermosensor- and <u>p</u>yruvate biosensor-based <u>l</u>ayered <u>c</u>ircuit, was created. Using <i>iso</i>-butylamine synthesis as a proof-of-concept, a 3.31-fold increase in titer was achieved by precisely fine-tuning cell metabolism and bioproduct synthesis, and its titer further reached 46.24 g/L in a fermenter. This work highlights powerful toolkits for regulating multigene pathways, enabling the efficient production of high-value bioproducts of industrial interest of industry.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144657841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuhui Cui, Duo Liu, Huimin Xue, Mingshan Li, Wenhong Guo, Cuiqin Huang, Xintian Zheng, Jichao Yang, Hong Liu, Huifang Yin, Hanjie Wang
{"title":"Metabolic Engineering of <i>Yarrowia lipolytica</i> with Massive Gene Assembly and Genomic Integration.","authors":"Yuhui Cui, Duo Liu, Huimin Xue, Mingshan Li, Wenhong Guo, Cuiqin Huang, Xintian Zheng, Jichao Yang, Hong Liu, Huifang Yin, Hanjie Wang","doi":"10.1021/acssynbio.5c00333","DOIUrl":"https://doi.org/10.1021/acssynbio.5c00333","url":null,"abstract":"<p><p>Synthetic biology has developed varied strategies of one-pot multigene assembly and genomic integration to promote the genetic engineering of the chassis. However, such strategies for engineering oleaginous yeast <i>Yarrowia lipolytica</i> is lacking, given the current stage that at most 5 exogenous genes (around 13 kb) can be assembled and integrated into the genome at once. Here, we developed a strategy of massive gene assembly and integration in the <i>Y. lipolytica</i> genome. As a proof of concept, dozen-gene assembly (more than 30 kb) and integration were achieved stably and reproducibly, and a <i>Y. lipolytica</i> chassis containing a total of 35 exogenous genes (a sum of 93.5 kb) was constructed. The introduction of massive genes modulated the synthesis of lycopene, a heterologous natural product, to quite different extents. Ultimately, an optimized constructed strain containing 15 exogenous genes achieved the highest yield of 144.58 mg/g DCW and produced a lycopene titer of 2144.83 mg/L in a 5 L bioreactor. Our strategy significantly expands the capability of <i>Y. lipolytica</i> genetic manipulation and metabolic engineering.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144657842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Progress in the Biosynthesis of Cosmetic Ingredients through Engineering of <i>Saccharomyces cerevisiae</i>.","authors":"Zhongjuan Di, Yanjun Huo, Guan Wang, Yingping Zhuang","doi":"10.1021/acssynbio.5c00199","DOIUrl":"https://doi.org/10.1021/acssynbio.5c00199","url":null,"abstract":"<p><p>Driven by consumer preferences for safety and environmental protection, the global cosmetics industry has an increasing demand for natural and sustainable ingredients. <i>Saccharomyces cerevisiae</i> has emerged as a powerful platform for the biosynthesis of cosmetic ingredients due to its strong metabolic capacity, genetic operability, and cost-effective production capabilities. This review focuses on the latest advances in <i>S. cerevisiae</i> for the production of high-value cosmetic compounds, including antioxidants, repair agents, moisturizers, and structure-maintaining ingredients. Key strategies, such as genetic and metabolic engineering, pathway modularity, and fermentation optimization, are discussed, demonstrating significant improvements in yield and efficiency. In addition, the integration of artificial intelligence and machine learning in strain design and process control is explored, providing promising solutions to overcome metabolic bottlenecks and scale up production. Despite challenges such as metabolic burden, <i>S. cerevisiae</i> shows great potential for sustainable and scalable biosynthesis of cosmetic ingredients, paving the way for the next generation of biobased cosmetics. This comprehensive review provides valuable insights and technical references for the development of the field of synthetic biology in the cosmetics industry.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144647956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zheng Lei, Xiangsong Chen, Lixia Yuan, Jinyong Wu, Jianming Yao
{"title":"Metabolic Control for High-Efficiency Ectoine Synthesis in Engineered <i>Escherichia coli</i>.","authors":"Zheng Lei, Xiangsong Chen, Lixia Yuan, Jinyong Wu, Jianming Yao","doi":"10.1021/acssynbio.5c00330","DOIUrl":"https://doi.org/10.1021/acssynbio.5c00330","url":null,"abstract":"<p><p>Ectoine is a pivotal natural osmoprotectant that functions as a compatible solute through osmoregulation, enabling microorganisms to thrive in extreme environments such as high salinity. To meet market demands, this study focuses on optimizing its production process. We initially engineered the <i>ectABC</i> gene cluster from <i>Halomonas venusta</i> via 5'-UTR modification, establishing a functional ectoine biosynthesis pathway in <i>E. coli</i>. Subsequent introduction of a rate-limiting enzyme EctB mutant (E407D) and aspartokinase mutant increased titer by 140%. To address lysine byproduct accumulation, an innovative molecular switch was employed to regulate <i>lysA</i> gene expression, achieving dynamic balance between cell growth and product synthesis. Further optimization through cofactor engineering yielded the final strain ECT31, which produced 164.6 g/L ectoine in a 100 L bioreactor within 117 h, the highest reported titer for <i>E. coli</i>-based ectoine production to date. The metabolic engineering strategy presented herein establishes a new pdigm for efficient biosynthesis of amino acid derivatives.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144635716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yi Torng Chai, Chee Mun Fang, Yin Sze Lim, Hwei-San Loh, Cheng Foh Le
{"title":"Directed Evolution for the Discovery of Engineered Proteins and Small Peptides Using Molecular Mutagenesis.","authors":"Yi Torng Chai, Chee Mun Fang, Yin Sze Lim, Hwei-San Loh, Cheng Foh Le","doi":"10.1021/acssynbio.4c00887","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00887","url":null,"abstract":"<p><p>Random mutagenesis is an essential technique in the directed evolution of proteins and peptides, driving advancements in protein engineering and biotechnology. This review provides a critical analysis of various error-prone polymerase chain reaction (epPCR) techniques employed for random mutagenesis, highlighting their mechanisms, advantages, and limitations. We compare conventional methods with emerging approaches, including combinative techniques and specialized protocols for small amplicons. We also discuss a few alternative approaches for cloning a mutant gene library, which could be simpler and more efficient than the traditional restriction digestion-ligation method, significantly improving the directed evolution workflows. Ultimately, the selection of a suitable method should align with the specific goals of the research, accepting inherent trade-offs. By combining different mutagenesis techniques with complementary mutational spectra, researchers can optimize their strategies for the discovery of novel proteins and peptides with specific biological activities and physicochemical properties of interest.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144635715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Metabolic Engineering of Methanotrophic Bacteria for <i>De Novo</i> Production of Taxadiene from Methane.","authors":"Xinzhe Zhang, Aipeng Li, Xiaohan Huang, Shuqi Guo, Chenyue Zhang, Ramon Gonzalez, Qiang Fei","doi":"10.1021/acssynbio.5c00109","DOIUrl":"https://doi.org/10.1021/acssynbio.5c00109","url":null,"abstract":"<p><p>The growing demand for natural products in pharmaceutical applications has prompted a focus on more sustainable methods to produce high-value terpenoids using microbial cell factories. Due to the characteristics of high abundance, renewable, and low cost, methane has emerged as a promising feedstock for biomanufacturing. In this study, the methanotrophic bacterium <i>Methylotuvimicrobium buryatenese</i> 5GB1C, known for its industrial potential, was metabolically engineered to synthesize taxadiene, a crucial precursor in paclitaxel production. The biosynthesis of taxadiene from methane was first established by employing an endogenous strong promoter to enhance the expression of heterologous taxadiene synthase in <i>M. buryatenese</i> 5GB1C. To further optimize the metabolic flux, rate-limiting enzymes (Dxs and IspA) were upregulated in the methylerythritol phosphate pathway while complementing the native pathway with the essential <i>idi</i> gene that was originally deficient. Coupled with a 2.1-fold improvement in the NADPH/NADP<sup>+</sup> ratio, these modifications collectively boosted taxadiene production from 2.58 to 22.97 mg/L in serum vials. Ultimately, a temperature-controlled two-stage cultivation was implemented in 3 L bioreactors, which achieved a remarkable titer of 104.88 mg/L, representing the highest reported titer for diterpenoid biosynthesis from methane. This work demonstrates the potential of utilizing methane for the sustainable production of advanced terpenoids with reduced environmental impact.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144624968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}